Breaking news

Yann LeCun Exits Meta To Pioneer Next-Generation AI Innovations

by THEFUTURE.TEAM

November 20, 2025

Yann LeCun, one of the seminal figures in modern artificial intelligence, has announced his departure from Meta to pursue an ambitious new venture in advanced machine intelligence. The move marks a significant turning point as LeCun endeavors to develop AI systems that can understand the physical world, remember persistently, reason through complexities, and plan intricate action sequences.

A Bold New Vision For Advanced Machine Intelligence

In a detailed LinkedIn post, LeCun outlined his plans to launch a startup focused on what researchers describe as world models—systems that extend beyond traditional web-based data analysis to capture the nuances of physical reality. His initiative, rooted in the Advanced Machine Intelligence (AMI) program he helped nurture at Meta’s FAIR lab and New York University, is set to redefine how AI interacts with the physical environment. LeCun clearly stated that the startup aims to ignite a revolution in the field by enabling systems with robust memory, reasoning capabilities, and complex planning.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Meta’s Shifting AI Landscape

The timing of LeCun’s exit coincides with a period of significant upheaval at Meta. The company recently restructured its AI research division following a lukewarm response to its open-source Llama model. As part of a sweeping overhaul, CEO Mark Zuckerberg has invested billions to attract premier AI talent, highlighted by a high-profile $14.5 billion deal with Scale AI and the recruitment of Alexandr Wang—a move which underscores Meta’s commitment to the competitive landscape dominated by giants such as OpenAI and Google.

Legacy, Partnerships, And The Future Of AI

LeCun’s tenure at Meta began in 2013 when he joined to lead the FAIR research team, a role that he simultaneously balanced with his academic commitments at New York University. He lauded his contributions to establishing FAIR as his most rewarding non-technical achievement. Reflecting on his journey, LeCun expressed gratitude toward influential figures like Mark Zuckerberg, Andrew Bosworth, Chris Cox, and Mike Schroepfer for their steadfast support of his work.

Despite departing from Meta, LeCun confirmed that the company will partner with his new venture, ensuring that the groundbreaking research initiated within FAIR continues to influence the broader industry. This collaboration highlights the nuanced balance between open-source research principles championed by LeCun and the proprietary, competitive strategies now shaping Silicon Valley’s approach to AI.

As LeCun embarks on this new chapter, his departure represents not only a personal milestone but also a broader shift in AI development. By venturing into uncharted territories of machine intelligence, LeCun aims to redefine the capabilities of artificial systems, setting the stage for innovations that could reshape industries and propel AI beyond its current limitations.

The Future Forbes Realty Global Properties

Colossal Biosciences Seeks Funding At Up To $30 Billion Valuation

Colossal Biosciences, the biotechnology startup known for its efforts to revive extinct species including the woolly mammoth and dire wolf, is in talks to raise funding at a valuation of $20 billion to $30 billion, according to Axios.

The company was last valued at $10.2 billion in a January funding round. It has since begun generating revenue, Axios reported, although neither the size of the new financing nor its potential investors have been disclosed.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Business Extends Beyond De-Extinction

While Colossal has attracted global attention for its de-extinction projects, the company is also building a broader biotechnology business around the tools developed through that research.

Co-founder and Chief Executive Ben Lamm has said Colossal expects revenue from three areas: conservation technologies, new businesses created from its research and future commercial applications of technologies developed alongside its de-extinction programme.

Expanding Commercial Portfolio

Colossal has already supplied conservation technology to the U.S. government and the United Arab Emirates, which recently invested $60 million in the company, according to Wired.

Its research has also led to the creation of several startups, including plastics recycling company Breaking, computational biology platform Form Bio, which raised $30 million, and AI-driven biology company Astromech, which was valued at $2 billion in March.

Research Continues To Expand

Operating from a 55,000-square-foot facility in Dallas, Colossal continues to broaden its research portfolio.

In April, the company added the bluebuck antelope as its sixth de-extinction target. More recently, the Colossal Foundation partnered with the University of Tasmania to develop vaccines and gene-editing approaches aimed at protecting Tasmanian devils from a contagious facial cancer.

Lamm has also said the company plans to spin out its artificial womb technology, which could eventually have applications in fertility treatment. Speaking to Rolling Stone in May, he said the technology could be ready next year.

Investor Interest In Deep Tech

The fundraising discussions come as investors increase spending on sectors such as biotechnology, longevity and other deep-tech fields.

Lamm has also said Colossal could eventually generate revenue from biodiversity credits if restored species are successfully reintroduced into their natural habitats, creating another potential commercial opportunity.